Abstract
Kaposi’s sarcoma (KS) is an enigmatic neoplasm that occurs commonly in several distinct clinical settings. The classic (endemic) form of KS most frequently occurs in certain Mediterranean Basin populations (especially Sephardic Jews) and African tribes (eg., Bantus) (Kaposi, 1872). An acquired form of KS occurs in patients treated with immunosuppressive agents, such as organ transplant recipients (Zibrob et al., 1980; Penn, 1987). Finally, the epidemic form of KS is found in association with Acquired Immunodeficiency Syndrome (AIDS) (Havercos et al, 1985; Safai et al., 1985; Mitsuyasu, 1988). AIDS-related KS tumors do not occur uniformly in all AIDS patients, but are usually restricted to one particular subset, homosexual males. This finding has given rise to speculation that additional factors besides the AIDS virus [HIV-1 (human immunodeficiency virus-type 1)] may be involved in the pathogenesis of this tumor. These factors may include infection with a second virus, including members of the human papilloma virus (HPV) and herpesvirus families (Huang et al., 1992; Nickoloff et al., 1992; Chang et al., 1994). Several studies suggest AIDS-related KS differs biologically from other forms of KS. While classic KS usually behaves as a indolent low grade disease with a protracted clinical course, AIDS KS is often clinically aggressive. The latter may be associated with significant morbidity and, in its most aggressive form, lethality (Bacchetti et al., 1988; Azon et al., 1990; Payne et al., 1990; Errante et al., 1991).
Keywords
- Hepatocyte Growth Factor
- Human Papilloma Virus
- Scatter Factor
- Rabbit Polyclonal Antiserum
- Phenotypic Conversion
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Azon-Masoliver A, Mallolas J, Miro JM, Gatell JM, Castel T, Iranzo P, Lecha M, Mascaro JM. Kaposi’s sarcoma associated with the acquired immunodeficiency syndrome. An analysis of 67 cases with a study of the prognostic factors. Med Clin Barcelona 95: 361–365, 1990.
Bacchetti P, Osmond D, Chaisson RE. Survival patterns of the first 500 AIDS patients in San Francisco. J Infect Dis 157: 1040–1047, 1988.
Bhargava M, Joseph A, Knesel J, Halaban R, Li Y, Pang S, Goldberg I, Setter E, Donovan MA, Zarnegar R, Michalopoulos GA, Nakamura T, Faletto D, Rosen EM. Scatter factor and hepatocyte growth factor: Activities, properties, and mechanism. Cell Growth & Differen 3:11–20, 1992.
Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802–804, 1991.
Bussolino F, DiRenzo MF, Ziche M, Bocchieto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629–641, 1992.
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266: 1865–1869, 1994.
Dorfman RF. Kaposi’s sarcoma revisited. Hum Pathol 15: 1013–1017, 1984.
Errante D, Tirelli U, Turnolo S. Management of AIDS and its neoplastic complications. Eur J Cancer 27:380–389, 1991.
Gherardi E, Gray J, Stoker M, Perryman M, Furlong R. Purification of scatter factor, a fibroblast-directed basic protein which modulates epithelial interactions and movement. PNAS USA 86: 5844–5818, 1989.
Gonzatti-Haces M, Seth A, Park M, Copeland T, Oroszlan S, Vande Woude GF. Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein tyrosine kinases. PNAS USA 85: 21–25, 1988.
Grant DS, Kleinman HK, Goldberg ID, Bhargava M, Nickoloff BJ, Polverini P, Rosen EM. Scatter factor induces blood vessel formation in vivo. PNAS USA 90: 1937–1941, 1993.
Havercos HW, Drotman DP, Morgan M. Prevalence of Kaposi’s sarcoma among patients with AIDS. N Engl J Med 321: 1518, 1985.
Huang YQ, Li JJ, Rush MG, Poiesz BJ, Nicolaides A, Jacobson M, Zhang WG, Coutavas E, Abbott MA, Friedman-Kien AE. HPV-16 related DNA sequences in Kaposi’s sarcoma. Lancet 399: 515–518, 1992.
Huang Y, Friedman-Kien, AE, Li JJ, Nickoloff, BJ. Cultured Kaposi’s sarcoma cell lines express factor XHIa, CD14, and VCAM-1, but not factor VIII or ELAM-1. Arch Dermatol 129: 1291–1296, 1993.
Inaba M, Koyama H, Hino M, Okuno S, Terada M, Nishizawa Y, Nishino T, Morii H. Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. Blood 82: 53–59, 1993.
Kaposi M. Idiopathic multiple pigmented sarcoma of the skin. Arch Dermatol Syphil 4: 265–274, 1872.
Kaposi M. (English Translation, CA - A Cancer J Clin 32: 342–347, 1982).
Leek RD, Harris AL, Lewis CE. Cytokine networks in solid human tumors: regulation of angiogenesis. J Leuk Biol 56: 423–435, 1994.
Li Y, Bhargava MM, Joseph A, Jin L, Rosen EM, Goldberg ID. The effect of scatter factor and hepatocyte growth factor on motility and morphology of non-tumorigenic and tumor cells. In Vitro Cell Dev Biol 30A: 105–110, 1994.
Miles SA, Rezai, AR, Salazar-Gonzalez JF, Vander Meyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martinez-Maza O. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 87: 4068–4072, 1990.
Miles SA, Martinez-Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, Radka SF, Linsley PS. Oncostatin M as a potent mitogen for AIDS-Kaposi’s sarcoma-derived cells. Science 255: 1432–1434, 1992.
Mitsuyasu RT. AIDS-related Kaposi’s sarcoma: a review of its pathogenesis and treatment. Blood Rev 2: 222–231, 1988.
Naidu YM, Rosen EM, Zitnik R, Goldberg I, Park M, Naujokas M, Polverini PJ, Nickoloff BJ. Role of scatter factor in the pathogenesis of AIDS-related Kaposi’s sarcoma. PNAS USA 91: 5281–5285, 1994.
Nakamura S, Salahuddin, SZ, Biberfeld P, Ensoli B, Markham PD, Wong-Staal F, Gallo RC. Kaposi’s sarcoma cells: Long-term culture with growth factor from retro virus-infected CD4+ cells. Science 242: 425–430, 1988.
Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440–443, 1989.
Nickoloff BJ, Griffiths CEM. Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi’s sarcomas. Science 243: 1736–1737, 1989a.
Nickoloff BJ, Griffiths CEM. The spindle-shaped cells in cutaneous Kaposi’s sarcoma. Am J Pathol 135: 793–800, 1989b.
Nickoloff BJ, Huang Y, Li J, Friedman-Kien AE. Immunohistochemical detection of papillomavirus antigens in Kaposi’s sarcoma. Lancet 339: 548–549, 1992.
Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer’s cells of damaged rat livers as revealed by in situ hybridization. Biochem Biophys Res Commun 173: 42–47, 1990.
Payne SF, Lemp GF, Rutherford GW. Survival following diagnosis of Kaposi’s sarcoma for AIDS patients in San Francisco. J Acquir Immune Defic Syndr 3 Suppl 1: S14–S17, 1990.
Penn I. Neoplastic consequences of transplantation and chemotherapy. Cancer Detect Prev (suppl) 1: 149–157, 1987.
Polverini PJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51: 635–642, 1984.
Ramakrishnan S, Xu FJ, Brandt SJ, Niedel JE, Bast RC Jr, Brown EL. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest 83: 921–926, 1989.
Rosen EM, Goldberg ID. Scatter factor and angiogenesis. Adv Cancer Res 67, In Press.
Rosen EM, Goldberg ID, Kacinski BM, Buckholz T, Vinter DW. Smooth muscle releases an epithelial cell scatter factor which binds to heparin. In Vitro Cell Dev Biol 25: 163–173, 1989.
Rosen, EM, Meromsky L, Setter E, Vinter DW, Goldberg ID. Purification and migration-stimulating activities of scatter factor. Proc Soc Exp Biol Med 195: 34–43, 1990.
Rosen EM, Goldberg ID, Liu D, Setter E, Donovan MA, Bhargava M, Reiss M, Kacinski BM. Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res 57: 5315–5321, 1991a.
Rosen EM, Grant D, Kleinman H, Jaken S, Donovan MA, Setter E, Luckett PM, Carley W. Scatter factor stimulates migration of vascular endothelium and capillary-like tube formation. In: “Cell Motility Factors”, Goldberg ID, Rosen EM, eds., Birkhauser-Verlag, Basel, 1991b, pp 76–88.
Rosen EM, Joseph A, Jin L, Rockwell S, Elias JA, Knesel J, Wines J, McClellan J, Kluger MJ, Goldberg ID, Zitnik R. Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 127: 225–234, 1994a.
Rosen EM, Nigam SK, Goldberg ID. Mini-Review: Scatter factor and the c-met receptor: A paradigm for mesenchymal:epithelial interaction. J Cell Biol 127: 1783–1787, 1994b.
Safai B, Johnson KG, Myskowski PL. The natural history of Kaposi’s sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 103: 744–750, 1985.
Salahuddin SZ, Nakamura S, Biberfield P, Kaplan MK, Markham PD, Larsson L, Gallo RC. Angiogenic properties of Kaposi’s sarcoma-derived cells after long-term culture in vitro. Science 242: 430–433, 1988.
Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 238–242, 1987.
Tamura M, Arakaki N, Tsoubouchi H, Takada H, Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J Biol Chem 268: 8140–8145, 1993.
Vogel J, Henrichs SH, Reynolds RK, Lucin PA, Jay G. The HIV tat gene induces dermal lesions resembling Kaposi’s sarcoma in transgenic mice. Nature 335: 606–611, 1988.
Weich HA, Salahuddin SZ, Gill P, Nakamura S, Folkman J. AIDS-associated Kaposi’s sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin. Am J Pathol 139, 1251–1258, 1991.
Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W. Scatter factor: Molecular characteristics and effect on invasiveness of epithelial cells. J Cell Biol 111: 2097–2108, 1990.
Wolf, H.K., Zarnegar, R., Michalopoulos, G.K. Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 14: 488–494, 1991.
Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 182: 802–809, 1992.
Zibrob Z, Haimov M, Schanzer H. Kaposi’s sarcoma after kidney transplantation. Transplantation 30: 383–384, 1980.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Rosen, E.M., Polverini, P.J., Nickoloff, B.J., Goldberg, I.D. (1996). Role of Scatter Factor in Pathogenesis of Aids-Related Kaposi Sarcoma. In: Maragoudakis, M.E. (eds) Molecular, Cellular, and Clinical Aspects of Angiogenesis. NATO ASI Series, vol 285. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0389-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0389-3_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8030-6
Online ISBN: 978-1-4613-0389-3
eBook Packages: Springer Book Archive